NESTcc Test-Case insights from Johnson & Johnson and Network Collaborator Lahey Hospital & Medical Center highlight the February issue of MedTech Strategist Market Pathways.

Johnson & Johnson has nearly completed a proactive post-market surveillance for safety and effectiveness of Class II lumbar interbody system device procedures. Real-World Evidence gathered from this and other NESTcc Test-Cases promises to open the door to new opportunities for device stakeholders to work together to share and leverage powerful real-world data—and shift the paradigm for how medtech innovates.

Read the article Real-World Evidence and Johnson & Johnson: NESTcc Unlocking Doors to Medical Device Innovation and Collaboration (subscription required).